In den vergangenen 15 Jahren wurden schon mehrfach Methoden der Zellapherese im
Rahmen der Therapie von chronisch entzündlichen Darmerkrankungen angewendet. Dabei …

Therapeutic apheresis, a novel approach for immunodisorders, has been used in the last
decade for the treatment of ulcerative colitis with promising result, and represents an …

Apheresis systems have been used in inflammatory bowel disease with a view to
immunomodulation. The technique employs a system of white cell extraction, filtration and …

Objective. Selective leukocyte apheresis is a new type of non-pharmacological treatment for
patients with active ulcerative colitis and Crohn's disease. Preliminary data have indicated …

Ziele: In einer Pilotstudie sollte die Wirksamkeit der Leukozytenapherese unter Verwendung
einer neuen Celluloseverbindung (GranuWash®, Membrana GmbH, Wuppertal)) bei …

In this review the current aspects concerning the application of leukocytapheresis in patients
with inflammatory bowel disease are briefly discussed. Leukocytapheresis has already been …

Initially used to treat rheumatoid arthritis, nonselective therapeutic leukocytapheresis was
applied to the treatment of inflammatory bowel disease (IBD) as early as the 1980s. Since …

Leukocytapheresis, device used to remove leukocytes from peripheral circulation, has been
approved for the treatment of active ulcerative colitis (UC) by the Ministry of Health and …

Die Colitis ulcerosa als eine Form der chronisch entzündlichen Darmerkrankungen ist
bedingt durch Störungen der intestinalen Immunregulation. Die zellulören Vorgönge sind …

Ulcerative colitis and Crohn's disease are inflammatory bowel diseases with a chronic
relapsing course. Management of both conditions is far from being fully satisfactory. For this …